Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Scientific animation of blood cells inside the lumen of a blood vessel

How and why do atherosclerotic plaques develop? Scientists already know  that turbulent blood flow patterns predispose arteries to develop plaques, but it’s been unclear how turbulence in blood vessels switches healthy endothelial cell lining into a disease state. Now, in a new study published in Science Advances, Professor Ellie Tzima’s group uses a multi-disciplinary approach to identify a molecular sensor for cellular transformation.

 In areas of turbulent flow, the healthy endothelium that lines and protects blood vessels starts transforming and transitioning into a mesenchymal phenotype, a process called endothelial-to-mesenchymal transition (EndMT). During this complex process, endothelial cells lose or reduce expression of their endothelial markers, and instead, start adopting a mesenchymal phenotype, characterised by expression of mesenchymal-specific proteins. Although EndMT is critical during embryonic development, it is also an important mechanism in the pathogenesis of several human diseases, including cancer, cardiovascular disease and even COVID-19 complications.

Professor Tzima and her team were able to identify a mechano-receptor expressed in endothelial cells that senses turbulent blood flow, and signals to set off a cascade of processes that shift cells towards this endothelial-to-mesenchymal transformation. 

 Professor Ellie Tzima said: “What is most fascinating is that application of force onto a single receptor is enough to induce a complex signalling pathway that will ultimately lead to endothelial transformation and atherosclerosis.

The role of haemodynamic forces as instigators and contributors to cardiovascular disease is now widely recognised. This study identifies novel therapeutic strategies to target the mechanobiology of endothelial cells in cardiovascular disease. “

Dr Vedanta Mehta, co-first author of the study said “It is indeed very interesting that a cellular receptor, previously only known to respond to biochemical stimuli, can also respond to mechanical forces to initiate pathological signalling that ultimately culminates in atherosclerosis.

 It is now widely appreciated that fluid forces play a major contribution towards the development of cardiovascular disorders, yet there is not a single therapy to date that targets mechanotransduction pathways to ameliorate pathogenesis. We hope that this study will pave the way for the development of novel ‘mechano-medicines’ to reduce the burden of heart disease”.

 Dr Kar Lai Pang, co-first author of the paper said: “It is intriguing that our group has discovered a novel mechanoreceptor that responds to turbulent blood flow which leads to EndMT pathophysiological process and atherosclerosis. Unveiling new novel molecular targets will enhance our understanding of disease pathways and hence development of new drugs and therapeutics approaches for the vascular disease.”

This work was undertaken in collaboration with researchers from Emory University and UNC, USA. The major funders were Wellcome and the British Heart Foundation.

Similar stories

Richard Tyser and Jack Miller honoured by the British Society of Cardiovascular Research

Dr Richard Tyser is this year’s winner of the Bernard and Joan Marshall Early Career Investigator Prize, and Dr Jack Miller has received a runner-up award, at the British Society of Cardiovascular Research Autumn Meeting.

Reducing fat in the diabetic heart could improve recovery from heart attack

New research from the Heather Group has shown that in type 2 diabetes an overload of lipids reduces the heart’s ability to generate energy during a heart attack, decreasing chances of recovery.

High blood sugar levels ‘reprogramme’ stem cells

Findings explain higher risk of heart attack in people with diabetes, even after treatment .

Critical six-week window to ‘reset’ blood pressure after giving birth

Home blood pressure monitors could help mothers significantly lower high blood pressure after pregnancy

Iron deficiency anaemia in early pregnancy increases risk of heart defects, suggests new research

In animal models, iron deficient mothers have a greatly increased risk of having offspring with congenital heart disease (CHD). The risk of CHD can be greatly reduced if the mother is given iron supplements very early in pregnancy. Additionally, embryos from a mouse model of Down Syndrome were particularly vulnerable to the effects of maternal iron deficiency, leading to a higher risk of developing severe heart defects.